Jill M. Quigley's most recent trade in Terns Pharmaceuticals Inc was a trade of 1,697 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharma Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2026 | 1,697 | 1,697 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.24 per share. | 04 Nov 2025 | 24,520 | 24,520 | - | 9.2 | 226,565 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2025 | 24,520 | 3,955 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 04 Nov 2025 | 24,520 | 0 | - | 18 | 441,360 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 10,657 | 10,657 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 5.79 per share. | 02 Jan 2025 | 8,760 | 0 | - | 5.8 | 50,758 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 5.72 per share. | 02 Jan 2025 | 6,240 | 8,760 | - | 5.7 | 35,702 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 17,235 | 0 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 09 Sep 2024 | 17,235 | 15,000 | - | 10 | 172,350 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. | 09 Sep 2024 | 17,235 | 32,235 | - | 1.8 | 31,368 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 01 Aug 2024 | 8,857 | 15,000 | - | 7.5 | 66,432 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 7.68 per share. | 01 Aug 2024 | 6,143 | 23,857 | - | 7.7 | 47,148 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 15 Jul 2024 | 14,365 | 30,000 | - | 10.0 | 143,660 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 14,365 | 17,635 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. | 15 Jul 2024 | 14,365 | 44,365 | - | 1.8 | 26,144 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 400 | 17,235 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 15 Jul 2024 | 400 | 30,000 | - | 10 | 4,000 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. | 15 Jul 2024 | 400 | 30,400 | - | 1.8 | 728 | Common Stock |
| Terns Pharma Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director, Sr. Advisor & Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 15,000 | 30,000 | - | 0 | Common Stock | |
| Terns Pharma Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Passage Bio Inc | Jill Quigley M. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.23 per share. | 08 Dec 2021 | 71,975 | 368,754 (0%) | 0% | 0.2 | 16,554 | Common Stock |
| Passage Bio Inc | M. Jill Quigley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 60,782 | 27,626 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | M. Jill Quigley | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 11,193 | 3,729 | - | - | Employee Stock Option (right to buy) | |
| Terns Pharma Inc | Jill M. Quigley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2021 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |